All News Releases

Alexion to Present at the BofA Merrill Lynch 2013 Healthcare Conference
5/8/13
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the BofA Merrill Lynch 2013 Healthcare Conference in Las Vegas at 8:00 a.m. Pacific time (11:00 a.m. Eastern time) on Wednesday, May 15, 2013. An audio webcast of Dr. Bell’s remarks will be available live. You can access the webcast at: www.alexionpharma.com. An archived versionmore...
Alexion Reports First Quarter 2013 Results
4/25/13
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results and a development pipeline update for the three months ended March 31, 2013. The Company reported net product sales of Soliris® (eculizumab) of $338.9 million, an increase of 38 percent from the same period in 2012. Revenue performance for the quarter reflects steady additions of new patients with paroxysmal nocturnal hemoglobinuria (PNH) globally, and an increasingmore...
Alexion Broadens and Strengthens its Executive Leadership Team
4/25/13
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that it is broadening and strengthening its executive leadership team in line with the Company’s expanding global mission to develop and commercialize life transforming therapies for patients with disorders that are severe, life-threatening, and ultra-rare. Stephen Squinto, Ph.D., co-founder of Alexion, is being promoted to the newly created position of Executive Vicemore...
Alexion Pharmaceuticals to Report First Quarter 2013 Results on Thursday, April 25, 2013
4/11/13
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the first quarter ended March 31, 2013 on Thursday, April 25, 2013 before the US financial markets open. Following the release of the financial results, Alexion management will conduct a conference call and audio web cast on Thursday, April 25, 2013, at 10:00 a.m. Eastern Time (ET). To participate in this conference call,more...
Alexion Joins the International Federation of Kidney Foundations in Celebrating World Kidney Day 2013
3/14/13
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced its support of World Kidney Day 2013, a global awareness campaign led by the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations. Celebrated on the second Thursday in March each year, the mission of World Kidney Day is to raise awareness of the importance of our kidneys to overall health and to reduce the incidence and impact of kidneymore...
Alexion to Present at the Barclays Global Healthcare Conference
3/5/13
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at the Barclays Global Healthcare Conference in Miami at 10:45 a.m. Eastern time on Tuesday, March 12, 2013. An audio webcast of Mr. Sinha’s remarks will be available live. You can access the webcast at: www.alexionpharma.com. An archived version of the remarks will also be available through themore...
Alexion Joins Eurordis, NORD and Patient Organizations Worldwide in Celebrating Rare Disease Day 2013
2/28/13
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN), joins the European Organization for Rare Diseases (EURORDIS), the National Organization for Rare Disorders (NORD) and patient organizations worldwide in celebrating Rare Disease Day 2013, a global effort to focus attention on rare diseases, their profound impact on patients, and the need for improved diagnosis and treatment. The theme of this year’s celebration, “Rare Disorders without Borders,”more...
Alexion to Present at the Cowen and Company 33rd Annual Health Care Conference
2/25/13
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the Cowen and Company 33rd Annual Health Care Conference in Boston at 2:10 p.m. Eastern time on Monday, March 4, 2013. An audio webcast of Dr. Bell’s remarks will be available live. You can access the webcast at: www.alexionpharma.com. An archived version of the remarks will also bemore...
Alexion Reports Fourth Quarter and Full Year 2012 Results
2/14/13
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results for the quarter and year ended December 31, 2012. For the three months ended December 31, 2012, Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") reported net product sales of Soliris® (eculizumab) of $320.5 million, compared to $227.6 million for the same period in 2011. The year-on-year increase in net product sales of 41 percent reflected steady additionsmore...
Alexion Recommends Rejection of Mini-Tender Offer by TRC Capital Corporation
2/7/13
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation to purchase up to 1.5 million shares, or approximately 0.77%, of the outstanding Alexion common stock at a price of $90.50 per share. TRC's offer price represents approximately a 5.06% discount to the closing price of Alexion common stock on February 5, 2013, the last closing price on the day prior to the date of themore...

Alexion Pharmaceuticals

Newsroom Search

Media Contacts

All News Releases